Literature DB >> 24463270

Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold.

Paola M Boggiatto1, Pedro A Martinez1, Ashok Pullikuth2, Douglas E Jones1, Bryan Bellaire3, Andrew Catling4, Christine Petersen5.   

Abstract

Leishmania amazonensis infection promotes alteration of host cellular signaling and intracellular parasite survival, but specific mechanisms are poorly understood. We previously demonstrated that L. amazonensis infection of dendritic cells (DC) activated extracellular signal-regulated kinase (ERK), an MAP-kinase kinase kinase, leading to altered DC maturation and non-healing cutaneous leishmaniasis. Studies using growth factors and cell lines have shown that targeted, robust, intracellular phosphorylation of ERK1/2 from phagolysosomes required recruitment and association with scaffolding proteins, including p14/MP1 and MORG1, on the surface of late endosomes. Based on the intracellular localization of L. amazonensis within a parasitophorous vacuole with late endosome characteristics, we speculated that scaffolding proteins would be important for intracellular parasite-mediated ERK signaling. Our findings demonstrate that MP1, MORG1, and ERK all co-localized on the surface of parasite-containing LAMP2-positive phagolysosomes. Infection of MEK1 mutant fibroblasts unable to bind MP1 demonstrated dramatically reduced ERK1/2 phosphorylation following L. amazonensis infection but not following positive control EGF treatment. This novel mechanism for localization of intracellular L. amazonensis-mediated ERK1/2 phosphorylation required the endosomal scaffold protein MP1 and localized to L. amazonensis parasitophorous vacuoles. Understanding how L. amazonensis parasites hijack host cell scaffold proteins to modulate signaling cascades provides targets for antiprotozoal drug development.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Dendritic cell; Leishmania; MAPK; MP1; Phagosome

Mesh:

Substances:

Year:  2014        PMID: 24463270      PMCID: PMC4023638          DOI: 10.1016/j.micinf.2013.12.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  31 in total

Review 1.  When kinases meet mathematics: the systems biology of MAPK signalling.

Authors:  Walter Kolch; Muffy Calder; David Gilbert
Journal:  FEBS Lett       Date:  2005-03-21       Impact factor: 4.124

2.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 3.  Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses.

Authors:  M A McDowell; D L Sacks
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

4.  Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.

Authors:  S Giroux; M Tremblay; D Bernard; J F Cardin-Girard; S Aubry; L Larouche; S Rousseau; J Huot; J Landry; L Jeannotte; J Charron
Journal:  Curr Biol       Date:  1999-04-08       Impact factor: 10.834

Review 5.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  The MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals.

Authors:  Ashok Pullikuth; Evangeline McKinnon; Hans-Joerg Schaeffer; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells.

Authors:  Ulrich Körner; Veronika Fuss; Jutta Steigerwald; Heidrun Moll
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase.

Authors:  Y Daaka; L M Luttrell; S Ahn; G J Della Rocca; S S Ferguson; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

9.  Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype.

Authors:  Amanda E Ramer; Yannick F Vanloubbeeck; Douglas E Jones
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma.

Authors:  G M Di Guglielmo; P C Baass; W J Ou; B I Posner; J J Bergeron
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  4 in total

Review 1.  Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms.

Authors:  Pedro A Martinez; Christine A Petersen
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

2.  Leishmania amazonensis-Induced cAMP Triggered by Adenosine A2B Receptor Is Important to Inhibit Dendritic Cell Activation and Evade Immune Response in Infected Mice.

Authors:  Amanda Braga Figueiredo; Míriam Conceição Souza-Testasicca; Tiago Wilson Patriarca Mineo; Luís Carlos Crocco Afonso
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

Review 3.  Apoptosis: Activation and Inhibition in Health and Disease.

Authors:  Sandra Georgina Solano-Gálvez; Jack Abadi-Chiriti; Luis Gutiérrez-Velez; Eduardo Rodríguez-Puente; Enrique Konstat-Korzenny; Diego-Abelardo Álvarez-Hernández; Giorgio Franyuti-Kelly; Laila Gutiérrez-Kobeh; Rosalino Vázquez-López
Journal:  Med Sci (Basel)       Date:  2018-07-04

Review 4.  The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids.

Authors:  Mercedes Soares-Silva; Flavia F Diniz; Gabriela N Gomes; Diana Bahia
Journal:  Front Microbiol       Date:  2016-02-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.